Alpha Cognition Inc (ACOG) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Alpha Cognition Inc (ACOG) has a cash flow conversion efficiency ratio of -0.158x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-5.35 Million) by net assets ($33.91 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Alpha Cognition Inc - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Alpha Cognition Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of Alpha Cognition Inc for a breakdown of total debt and financial obligations.
Alpha Cognition Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Alpha Cognition Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bellevue Group AG
SW:BBN
|
0.150x |
|
Nyxoah
BR:NYXH
|
-0.402x |
|
Woorim Machinery Co. Ltd
KQ:101170
|
-0.035x |
|
Easy Field
TWO:6425
|
-0.057x |
|
Aesler Grup Internasional Tbk Pt
JK:RONY
|
-1.290x |
|
HYUNDAI FEED Inc
KQ:016790
|
0.015x |
|
Kyung Nong Corporation
KO:002100
|
0.043x |
|
Megaforce Co Ltd
TWO:3294
|
-0.004x |
Annual Cash Flow Conversion Efficiency for Alpha Cognition Inc (2020–2024)
The table below shows the annual cash flow conversion efficiency of Alpha Cognition Inc from 2020 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Alpha Cognition Inc worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $41.46 Million | $-7.76 Million | -0.187x | -110.10% |
| 2023-12-31 | $-4.71 Million | $-8.73 Million | 1.852x | -73.54% |
| 2022-12-31 | $-1.32 Million | $-9.24 Million | 7.000x | +739.82% |
| 2021-12-31 | $9.03 Million | $-9.88 Million | -1.094x | +99.68% |
| 2020-12-31 | $16.01K | $-5.44 Million | -339.684x | -- |
About Alpha Cognition Inc
Alpha Cognition Inc., a biopharmaceutical company, engages in the development of treatments for patients suffering from neurodegenerative diseases in the United States and Canada. The company's commercial development program includes ZUNVEYL oral tablet formulation for treating Alzheimer's disease. Its pre-clinical development programs comprise ZUNVEYL in combination with memantine for the treatm… Read more